Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on September 1, 2026

Sep. 1, 2026

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Tarsus to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

Demeterherb: Leading Pure NMN Powder Manufacturer in China with TÜV Rheinland Factory Certification

Indeterminate EIN Presswire

Sep. 1, 2026

Luxury Hotels Market Poised to Reach USD 214.46 Billion by 2035 as Personalized Experiences Reshape Hospitality

Indeterminate EIN Presswire

Sep. 1, 2026

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Ryman Hospitality Properties, Inc. Closes Acquisition of Grande Lakes Orlando Resort and Updates 2026 Outlook

Indeterminate GlobeNewswire

Sep. 1, 2026

XT Exchange Welcomes HKB1, Bridging Blockchain With Global Commerce

Indeterminate GlobeNewswire

Sep. 1, 2026

LifeStance to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15

Indeterminate GlobeNewswire

Sep. 1, 2026

Sana Biotechnology to Present at September 2026 Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Cytek Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Oil-Dri Announces Dates for Fourth Quarter and Fiscal Year 2026 Earnings Release and Live Webcast

Indeterminate GlobeNewswire

Sep. 1, 2026

CAMP4 to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Lexicon Pharmaceuticals to Participate at Three Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of GENGLYCOS™ (also known as DTX401) AAV Gene Therapy in GSDIa in The Journal of Inherited Metabolic Disease

Indeterminate GlobeNewswire

Sep. 1, 2026

Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

BBOT to Participate in Upcoming Investor Healthcare Conferences

Indeterminate GlobeNewswire